Andrew Drechsler
Director/Board Member en BAUDAX BIO, INC. .
Fortuna: 23 $ al 29/02/2024
Perfil
Andrew T.
Drechsler is on the board of Baudax Bio, Inc.
In the past Mr. Drechsler held the position of Chief Financial Officer for Insmed, Inc., Chief Financial Officer of VaxInnate Corp., Controller of Abbott Laboratories and Controller at i-STAT Corp.
(a subsidiary of Abbott Laboratories), Chief Financial Officer at Valera Pharmaceuticals, Inc., Chief Financial Officer at Provention Bio, Inc., Principal at Coopers & Lybrand LLP and Controller at Biomatrix, Inc.
Mr. Drechsler received an undergraduate degree from Villanova University.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
BAUDAX BIO INC
0.00% | 07/09/2023 | 1 040 ( 0.00% ) | 23 $ | 29/02/2024 |
Cargos activos de Andrew Drechsler
Empresas | Cargo | Inicio |
---|---|---|
BAUDAX BIO, INC. | Director/Board Member | 20/08/2020 |
Antiguos cargos conocidos de Andrew Drechsler.
Empresas | Cargo | Fin |
---|---|---|
PROVENTION BIO, INC. | Director of Finance/CFO | 01/12/2021 |
INSMED INCORPORATED | Director of Finance/CFO | 01/03/2017 |
VaxInnate Corp.
VaxInnate Corp. Pharmaceuticals: MajorHealth Technology VaxInnate Corp. develops novel, proprietary vaccines for infectious diseases. It engages in the development and production of vaccines for pandemic and seasonal influenza diseases. The firm's products include Flagellin.HuHA and flagellin.AvHA, which are fusion proteins linking a potent immune stimulator, the bacterial protein flagellin, with immunoprotective domain of viral hemagglutinin. The company was founded by Ruslan Medzhitov, Michael I. Sherman and Richard Flavell in 2002 and is headquartered in Cranbury, NJ. | Director of Finance/CFO | 01/11/2012 |
Valera Pharmaceuticals, Inc.
Valera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Valera Pharmaceuticals, Inc. develops and commercializes products for the treatment of urology and endocrine conditions, diseases and disorders. The Company was founded in 1972 and is located in Cranbury, NJ. | Director of Finance/CFO | 18/04/2007 |
i-STAT Corp.
i-STAT Corp. Medical SpecialtiesHealth Technology i-STAT Corp. is used to develope, manufacture and market medical diagnostic products for blood analysis that provide healthcare professionals critical diagnostic information accurately and immediately at the point of patient care. Founded in 1983 by Imants Lauks, i-STAT was headquartered in East Windsor, NJ. | Comptroller/Controller/Auditor | 01/01/2005 |
Formación de Andrew Drechsler.
Villanova University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
ABBOTT LABORATORIES | Health Technology |
INSMED INCORPORATED | Health Technology |
Empresas privadas | 7 |
---|---|
i-STAT Corp.
i-STAT Corp. Medical SpecialtiesHealth Technology i-STAT Corp. is used to develope, manufacture and market medical diagnostic products for blood analysis that provide healthcare professionals critical diagnostic information accurately and immediately at the point of patient care. Founded in 1983 by Imants Lauks, i-STAT was headquartered in East Windsor, NJ. | Health Technology |
Biomatrix, Inc.
Biomatrix, Inc. Pharmaceuticals: MajorHealth Technology Biomatrix, Inc. develops, manufactures, markets and sells a series of proprietary viscoelastic products called 'hylans'. Hylans are the second generation of viscoelastics used in medicine and are characterized by significantly enhanced physical properties such as elasticity, viscosity and pseudoplasticity. These products are used in therapeutic medical applications and skin care. The company was founded by Endre A. Balazs and Janet L. Denlinger in 1981 and is headquartered in Ridgefield, NJ. | Health Technology |
Valera Pharmaceuticals, Inc.
Valera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Valera Pharmaceuticals, Inc. develops and commercializes products for the treatment of urology and endocrine conditions, diseases and disorders. The Company was founded in 1972 and is located in Cranbury, NJ. | Health Technology |
Coopers & Lybrand LLP | Commercial Services |
VaxInnate Corp.
VaxInnate Corp. Pharmaceuticals: MajorHealth Technology VaxInnate Corp. develops novel, proprietary vaccines for infectious diseases. It engages in the development and production of vaccines for pandemic and seasonal influenza diseases. The firm's products include Flagellin.HuHA and flagellin.AvHA, which are fusion proteins linking a potent immune stimulator, the bacterial protein flagellin, with immunoprotective domain of viral hemagglutinin. The company was founded by Ruslan Medzhitov, Michael I. Sherman and Richard Flavell in 2002 and is headquartered in Cranbury, NJ. | Health Technology |
Baudax Bio, Inc. | |
Provention Bio, Inc.
Provention Bio, Inc. Pharmaceuticals: MajorHealth Technology Provention Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics and solutions. Its products include PRV-031 for the interception of type 1 diabetes (T1D), PRV-015 for the treatment of gluten-free diet non-responding celiac disease, PRV-6527 for Crohn’s disease, PRV-3279 for the treatment of lupus, and PRV-101 for the prevention of acute coxsackie virus B (CVB), and the prevention of type 1 diabetes (T1D) onset. The company was founded by Francisco Leon and Ashleigh Palmer on October 4, 2016 and is headquartered in Red Bank, NJ. | Health Technology |